Author: ParadigMS Foundation

Expert meeting, Virtual

ParadigMS board members meet virtually in April. At the Expert Meetings, experts peer review each others educational slide decks with the objective to publish educational materials for clinical neurologists and nurses on behalf of ParadigMS. EXPERT DIGITAL MEETING Sat 24 APRIL 2021 The following ‘hot topics’ are on the agenda: Innate immunity in MS and the role of microglia (Lead authors: Patrick Vermersch, Laura Airas) Second line treatments in MS (Lead authors: Raed Alroughani, Bassem Yamout) Virtual care of patients with MS (Lead authors: Mona Alkhawajah, Carlo Pozzilli) COVID-19 experiences...

Continue reading

E-workshop – MRI in MS & Management during a pandemic

21th November 2020, ParadigMS Foundation and MENACTRIMS offered an enriching e-workshop and keynote – MRI in MS // Management during a pandemic. Here you can review the full recording. ABSTRACTSMRI IN MSROULA HOURANI & JENS WÜRFEL Magnetic resonance imaging (MRI) plays a fundamental role in the diagnosis and management of the multiple sclerosis (MS) patient.ParadigMS and MENACTRIMS have joined forces to bring you an interactive e-workshop on MRI in MS presented by the eminent neuroradiologists Dr. Roula Hourani (American University of Beirut Medical Center, Lebanon) and Dr....

Continue reading

Expert meeting, Virtual

The ParadigMS Board Members will meet in October virtually. There are a number of new topics on the agenda. In addition, there will also be a number of (second) reviews of current subjects. EXPERT DIGITAL MEETING OCTOBER 2020 The following ‘hot topics’ are on the agenda: NEW: Innate immunity in MS and the role of microglia (lead authors: Patrick Vermersch and Laura Airas) NEW: Virtual care of patients with MS  (lead authors: Carlo Pozzilli and Mona Alkhawajah) NEW: Precision Medicine in MS (lead authors: Nikolaos Grigoriadis + co-author to be assigned) SECOND REVIEW: DMT’s in MS (lead...

Continue reading

  • 1
  • 2

Subscribe to our bi-annual Newsletter

ParadigMS does not send eNewsletters that contain advertisements and we do not share your contact details with sponsors (unless we received your explicit consent)